Hisamitsu Wins FDA Approval For Company's First Drug In U.S. Market
This article was originally published in PharmAsia News
Executive Summary
Hisamitsu Pharmaceutical said the U.S. FDA has cleared its pain reliever delivered by skin patch for the American market